iNeo-Vac-R01

N/A

Report date: 2026/02/11 17:52:16

Base Information

Drug NameiNeo-Vac-R01
Drug Alias NamePersonalized mRNA Vaccine Encoding Neoantigen AlonePersonalized mRNA vaccine encoding neoantigeniNeo-Vac-R01
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsBile Duct Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Neoantigen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Neoantigen TherapeuticsZhejiang University
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsBile Duct Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A